Muqeem Ahmed, UK,

Rift between global vaccine maker AstraZeneca and the European Union have ended. AstraZeneca has stated that readiness to supply vaccines in future to European Union.

According to company 60 million doses will be provided in the third quarter of this year while the remaining 75 million doses will be provided in the last quarter of the year. Following the agreement, the European Union will suspend legal proceedings against AstraZeneca The European Commission sued AstraZeneca for violating the agreement and failing to deliver the required number of vaccines in April. Under the new agreement, the company will be obliged to provide concessions to the European Union, in case of delay in delivery of vaccines.

AstraZeneca’s share price has risen since the news broke.

This post was originally published on VOSA.